drugset / Trial / NCT03316690

The Interaction Between Metformin and Physical Training

NCT03316690 ↗

RandomizedParallel-groupTriple-blindBasic science

Summary

Physical activity is a first line treatment for patients with type 2 diabetes (T2D), however, the vast majority of patients with T2D do not achieve satisfying glycemic control with physical activity alone, which is why pharmacological treatment with metformin is most often initiated. It is known that metformin and exercise both activates 5' adenosine monophosphate-activated protein kinase (AMPK) in skeletal muscle and liver, and the activation of AMPK results in many different metabolic effects, including improvements in glycemic control. Because of this similarity in mechanism of action, an interaction between metformin and exercise is plausible, but knowledge in the area is sparse. Thus, the aim of this study is to assess the effects of training with and without concomitant metformin treatment, in order to investigate whether an interaction between the two occur. Subjects with impaired glucose tolerance will all undergo 12 weeks of training but will be randomized (1:1) to concomitant metformin/placebo treatment in a double-blinded way. Experimental days will be performed before randomisation (before initiation of metformin/placebo treatment), before initiation of the training period and after the training period.

Timeline

Start
2017-10-20
Primary completion
2018-10-01
Completion
2018-10-01

Outcome

Missed primary endpoint

paper Postprandial glucose improved from BASELINE to TRAINING in both the PLA group and the MET group (∆PLA: -0.7 [95% CI -1.4, 0.0] mmol/l, p = 0.05 and ∆MET: -0.7 [-1.5, -0.0] mmol/l, p = 0.03), with no between-group difference (p = 0.92). PMID 32979074 ↗

paper Metformin plus exercise training was not superior to exercise training alone in improving postprandial glucose. PMID 32979074 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —